Literature DB >> 25681058

Quality of Life after Ventral Hernia Repair with Endoscopic Component Separation Technique.

C Ø Thomsen1, T L Brøndum2, L N Jørgensen2.   

Abstract

BACKGROUND AND AIMS: Large ventral hernias are often associated with physical, social, and health problems for the patient, and surgical repair remains a challenge. Open components separation has widely been applied to obtain closure of the midline and recently a minimally invasive technique has been introduced (endoscopic components separation). The effectiveness and safety of endoscopic components separation have been demonstrated in previous reports, whereas little is known about quality of life in these patients. With a focus on quality of life, we present the first patients from our center operated on with endoscopic components separation.
MATERIAL AND METHODS: A total of 19 consecutive patients scheduled for open hernia repair with endoscopic components separation from October 2010 to June 2012 were included. All procedures included endoscopic components separation because of the hernia size. Demographic data, operative information, and postoperative complications were recorded. All patients completed two similar questionnaires regarding their function level, cosmetic satisfaction, analgesic medication, alcohol consumption, and self-estimated physical and mental health before and after the hernia repair. Patients were assessed as outpatient median 2 months and 16 months after operation for exclusion of hernia recurrence and completion of the postoperative questionnaire. RESULTS AND
CONCLUSIONS: Operating room time was median 204 min and correlated significantly with the hernia size. A total of 21 postoperative complications occurred in 14 patients. The length of stay was median 6 days and correlated significantly with duration of the operation. Of these, 15 patients participated in late follow-up visit. Two patients experienced recurrent hernias. Postoperative function level, cosmetic satisfaction, and self-estimated physical and mental health improved significantly. Alcohol consumption was significantly reduced. Endoscopic components separation is a reliable method to repair large ventral hernias, although further studies are required to determine the exact benefits for endoscopic components separation hernia repair versus conventional hernia repair. © The Finnish Surgical Society 2015.

Entities:  

Keywords:  Large ventral hernia; endoscopic component separation; outcome; quality of life

Mesh:

Year:  2015        PMID: 25681058     DOI: 10.1177/1457496915571402

Source DB:  PubMed          Journal:  Scand J Surg        ISSN: 1457-4969            Impact factor:   2.360


  6 in total

Review 1.  Minimally invasive component separation technique for large ventral hernia: which is the best choice? A systematic literature review.

Authors:  Andrea Balla; Isaias Alarcón; Salvador Morales-Conde
Journal:  Surg Endosc       Date:  2019-10-04       Impact factor: 4.584

2.  Giant ventral hernia-relationship between abdominal wall muscle strength and hernia area.

Authors:  K Strigård; L Clay; B Stark; U Gunnarsson; P Falk
Journal:  BMC Surg       Date:  2016-08-02       Impact factor: 2.102

3.  Bridged repair of large ventral hernia defects using an ovine reinforced biologic: A case series.

Authors:  George DeNoto
Journal:  Ann Med Surg (Lond)       Date:  2022-03-02

4.  Quality of Life after Complex Abdominal Wall Reconstruction.

Authors:  Mark Philipp; Matthias Leuchter; Ernst Klar
Journal:  Visc Med       Date:  2020-01-14

5.  What Do We Know About Component Separation Techniques for Abdominal Wall Hernia Repair?

Authors:  Hubert Scheuerlein; Andreas Thiessen; Christine Schug-Pass; Ferdinand Köckerling
Journal:  Front Surg       Date:  2018-03-27

Review 6.  Measuring quality of life in patients with abdominal wall hernias: a systematic review of available tools.

Authors:  T N Grove; L J Muirhead; S G Parker; D R L Brogden; S C Mills; C Kontovounisios; A C J Windsor; O J Warren
Journal:  Hernia       Date:  2020-05-15       Impact factor: 4.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.